However, Nur77/TR3, an orphan nuclear receptor, can bind to Bcl-B and transform its antiapoptotic phenotype into a proapoptotic one via conformational changes in its structure that expose its BH3 domain and subsequent exertion of proapoptotic activity in plasma and myeloma cells [30, 31]. The gene discussed is NR4A1; the disease is plasma cell myeloma.